arginine has been researched along with Encephalopathy, Toxic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, X; Li, Y; Wang, Z; Wu, C; Zhang, B; Zhang, J; Zhang, Y; Zhou, Z | 1 |
| Buchan, AM; Harston, GW; Kennedy, J; Sutherland, BA | 1 |
| Belenichev, IF; Sokolik, EP | 1 |
| Araki, T; Imai, Y; Itoyama, Y; Kato, H; Kurosaki, R; Matsubara, M; Michimata, M; Mikami, T; Muramatsu, Y | 1 |
| Bağirici, F; Bostanci, MO | 1 |
| Al-Rubai, AJ; Grabowska, AM; Ivanov, DP; Pratten, MK | 1 |
1 review(s) available for arginine and Encephalopathy, Toxic
| Article | Year |
|---|---|
The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity.
Topics: Animals; Arginine; Brain; Brain Ischemia; Cerebrovascular Circulation; Drug Interactions; Drug Stability; Fibrinolytic Agents; Humans; Isoenzymes; Neurotoxicity Syndromes; Neurotoxins; Nitric Oxide; Nitric Oxide Synthase; Receptors, LDL; Receptors, N-Methyl-D-Aspartate; Recombinant Proteins; Severity of Illness Index; Tissue Plasminogen Activator | 2010 |
5 other study(ies) available for arginine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Integrated metabolomic and transcriptomic analysis reveals perturbed glycerophospholipid metabolism in mouse neural stem cells exposed to cadmium.
Topics: Animals; Arginine; Cadmium; Glycerophospholipids; Metabolomics; Mice; Neurotoxicity Syndromes; Transcriptome | 2023 |
[Pharmacological modulation of nitrogen oxide system in experimental chronic alcoholic intoxication in rats].
Topics: Alcoholism; Amino Acids; Animals; Animals, Outbred Strains; Arginine; Catalase; Complex Mixtures; Disease Models, Animal; Drug Administration Schedule; Intercellular Signaling Peptides and Proteins; Male; Neuropeptides; Neuroprotective Agents; Neurotoxicity Syndromes; Nitric Oxide; Nitric Oxide Synthase; Peptides; Rats; Superoxide Dismutase | 2011 |
Therapeutic effect of neuronal nitric oxide synthase inhibitor (7-nitroindazole) against MPTP neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Arginine; Brain Chemistry; Dopamine; Dopamine Agents; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; Immunohistochemistry; Indazoles; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Neostriatum; Neurotoxicity Syndromes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Pargyline; Tyrosine 3-Monooxygenase | 2002 |
Nitric oxide synthesis inhibition attenuates iron-induced neurotoxicity: a stereological study.
Topics: Animals; Arginine; Disease Models, Animal; Drug Interactions; Enzyme Inhibitors; Hippocampus; Iron; Male; Neurons; Neurotoxicity Syndromes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Stereotaxic Techniques | 2008 |
Separating chemotherapy-related developmental neurotoxicity from cytotoxicity in monolayer and neurosphere cultures of human fetal brain cells.
Topics: Antineoplastic Agents; Astrocytes; Brain; Cell Count; Cell Culture Techniques; Cell Survival; Cells, Cultured; Etoposide; Fetus; Glial Fibrillary Acidic Protein; Humans; Methylmercury Compounds; Neurons; Neurotoxicity Syndromes; Oxazines; Oxidation-Reduction; Spheroids, Cellular; Teniposide; Tubulin; Xanthenes | 2016 |